Bovine Tuberculosis: Diagnostic Advances and Control Strategies in Cattle

Introduction

Bovine tuberculosis (bTB) is a chronic infectious disease of cattle caused primarily by Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex. The disease imposes substantial economic burdens on the livestock industry through production losses, trade restrictions, and the costs of surveillance and eradication programs. M. bovis also exhibits a broad host range, including wildlife reservoirs that complicate control efforts. The interplay between domestic cattle and wildlife has been extensively documented, and the importance of understanding reservoir dynamics is critical for eradication [1, 2]. This article reviews the current state of diagnostic technologies and control strategies for bTB, with emphasis on the comparative intradermal test, gamma-interferon assay, and molecular typing methods. For a parallel discussion of wildlife reservoirs, refer to the article Mycobacterium bovis in Wildlife: Reservoir Dynamics and Implications for Cattle Tuberculosis Eradication.

Pathogen Biology and Host Interaction

M. bovis is a facultative intracellular bacillus that primarily infects the respiratory tract. Transmission occurs via aerosolized droplets from infectious animals, although ingestion of contaminated feed or water can also occur, especially in young calves. After inhalation, the bacteria are phagocytosed by alveolar macrophages but resist intracellular killing by inhibiting phagosome-lysosome fusion [3]. The pathogen then disseminates to regional lymph nodes, particularly the retropharyngeal and bronchomediastinal lymph nodes, where granulomatous lesions develop. The host immune response is characterized by a T-helper 1 (Th1) response, with key roles for interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) [4]. Cell-mediated immunity (CMI) is the primary protective mechanism, and its detection forms the basis of the most widely used diagnostic assays.

Diagnostic Modalities

Diagnosis of bTB relies on a combination of ante-mortem immunological tests and post-mortem examination with bacteriological confirmation. The choice of test depends on the testing purpose (herd screening, individual animal diagnosis, or international trade) and the prevalence of the disease in the region.

Comparative Intradermal Test (CIT)

The comparative intradermal test (CIT), also known as the comparative cervical tuberculin test, remains the standard screening test in many national eradication programs. The test measures delayed-type hypersensitivity (DTH) to purified protein derivatives (PPDs) from M. bovis (bovine tuberculin) and M. avium (avian tuberculin). Two injections are administered intradermally in the mid-cervical region, and the skin-fold thickness is measured before and 72 hours after injection [5]. The interpretation is based on the difference in swelling: a larger response to bovine PPD compared to avian PPD indicates exposure to M. bovis.

Table 1 presents typical interpretation criteria used in official programs.

The CIT is relatively inexpensive and simple to perform in field conditions, but its sensitivity and specificity vary. Sensitivity ranges from 68% to 95% depending on disease severity and the cutoff used, while specificity is generally high (greater than 99%) in non-infected populations [6]. False-positive reactions can occur due to sensitization by environmental mycobacteria or due to cross-reactions with M. avium subsp. paratuberculosis [7].

Gamma-Interferon (IFN-gamma) Assay

The IFN-gamma assay, based on the detection of cytokine release from whole blood stimulated with PPDs, provides an alternative to the CIT. The assay uses a commercial enzyme-linked immunosorbent assay (ELISA) platform to measure IFN-gamma production after 16 to 24 hours of incubation [8]. The test is more sensitive than the CIT, particularly in early infection, and can detect infected animals earlier in the disease course [9]. However, specificity is slightly lower due to similar cross-reactivity issues.

The IFN-gamma assay is often used as a supplementary test in parallel with the CIT to maximize sensitivity, especially in high-prevalence herds or in officially tuberculosis-free (OTF) regions where the goal is eradication. For example, the European Union allows the use of the IFN-gamma assay for confirmatory testing of CIT-positive or inconclusive animals [10]. The assay requires laboratory infrastructure, blood sample handling within 8 hours, and strict quality control.

For a detailed discussion of ELISA methodology, readers are directed to the article Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus: p27 Antigen Detection and Diagnostic Interpretation, which describes the biophysical principles underlying antigen capture and detection.

Molecular Diagnostic Methods

Direct detection of M. bovis DNA has become increasingly important for rapid confirmation and epidemiological typing. Polymerase chain reaction (PCR) assays targeting the insertion sequence IS6110 (common to the MTBC) or the RvD1 region specific to M. bovis offer high sensitivity and specificity [11]. Real-time PCR (qPCR) allows quantification and rapid turnaround time, with results available within a few hours from tissue samples or respiratory specimens [12]. However, PCR on ante-mortem samples (e.g., nasal swabs, bronchoalveolar lavage, or milk) suffers from lower sensitivity due to intermittent shedding and low bacterial loads [13].

Culture and Identification

Mycobacterial culture on solid media (e.g., Löwenstein-Jensen or Stonebrink) or liquid systems (e.g., BACTEC MGIT) remains the gold standard for definitive diagnosis. Culture can take 4 to 8 weeks for solid media, whereas liquid systems reduce this to 1 to 3 weeks [14]. Biochemical tests and molecular probes are used to differentiate M. bovis from other MTBC members.

Molecular Typing for Epidemiological Surveillance

Genotyping of M. bovis isolates is essential for tracking transmission routes and identifying wildlife reservoirs. The two primary techniques are:

• Spoligotyping: Spacer oligonucleotide typing targets the direct repeat (DR) region of the M. bovis genome. It generates a pattern of 43 spacers that can be compared to international databases (e.g., SpolDB4) [15].
• Variable Number Tandem Repeat (VNTR) typing: Analysis of multiple loci (e.g., ETR-A through ETR-F, QUB, Mtub) provides higher discriminatory power than spoligotyping alone [16]. The combination of both methods is recommended for optimal strain differentiation.

Whole-genome sequencing (WGS) is now entering the diagnostic realm, offering unparalleled resolution for outbreak investigations and identification of cross-species transmission events [17]. WGS can detect single-nucleotide polymorphisms (SNPs) that distinguish closely related isolates, enabling precise mapping of infection networks.

Diagnostic Algorithm

A stepwise diagnostic algorithm is commonly implemented in bTB control programs. The following Mermaid diagram outlines a typical decision flow for test-positive animals in a herd undergoing eradication.

graph TD
    A[Herd screening with CIT], > B{Result}
    B, > |Negative| C[No action]
    B, > |Inconclusive| D[IFN-gamma assay after 60 days]
    B, > |Positive| E[Slaughter with post-mortem inspection]
    D, > F{IFN-gamma result}
    F, > |Negative| C
    F, > |Positive| E
    E, > G{Tissue lesions present?}
    G, > |Yes| H[Collect samples for culture and PCR]
    G, > |No| I[Consider ancillary testing]
    H, > J[Mycobacterial culture confirmation]
    J, > K[Genotyping for molecular epidemiology]
    K, > L[Inform herd management and trace-back]
    I, > J

Control Strategies

Test-and-Slaughter

The cornerstone of bTB control in most developed countries is the test-and-slaughter policy. Reactor animals identified by CIT or IFN-gamma assay are removed from the herd and slaughtered, with compensation provided to farmers [18]. Whole-herd depopulation is reserved for severe outbreaks. This approach, combined with movement restrictions and abattoir surveillance, has successfully reduced prevalence in countries such as Australia and several European Union member states [19].

Biosecurity and Herd Management

Biosecurity measures aim to prevent introduction of M. bovis into herds and to minimize transmission within infected herds. Key practices include:

• Purchase testing: Quarantine and test all incoming cattle before introduction to the main herd [20].
• Separation of age groups: Youngstock are less likely to transmit infection but can become infected from adult animals in shared housing [21].
• Ventilation and stocking density: Reducing aerosol transmission by improving barn ventilation and avoiding overcrowding [22].
• Manure management: Proper disposal of slurry to prevent fecal-oral transmission, especially from infected animals with advanced lesions.

Wildlife Management

In many regions, wildlife reservoirs such as the Eurasian badger (Meles meles), the brushtail possum (Trichosurus vulpecula), and white-tailed deer (Odocoileus virginianus) maintain M. bovis infection and spill back into cattle [23, 24]. Control measures include culling, vaccination (e.g., BCG for badgers), and fencing to separate cattle from wildlife. The article Mycobacterium bovis in Wildlife: Reservoir Dynamics and Implications for Cattle Tuberculosis Eradication provides further details on this interface.

Vaccination of Cattle

BCG (Bacille Calmette-Guérin) vaccination of cattle has been investigated as a tool to reduce disease prevalence. While BCG can induce partial protection against M. bovis challenge, it interferes with DTH-based diagnostic tests, making test-and-slaughter programs difficult to reconcile with vaccination [25]. Development of DIVA (differentiating infected from vaccinated animals) vaccines and companion diagnostic tests is an active research area. Candidate antigens such as ESAT-6, CFP-10, and Rv3615c allow discrimination of infected from BCG-vaccinated animals using IFN-gamma assays [26].

Antimicrobial Stewardship

Treatment of bTB in cattle is not recommended due to the chronic nature of infection, the risk of developing antimicrobial resistance, and the difficulty in achieving bacteriological cure. Furthermore, treated animals may remain carriers and shed bacteria intermittently [27]. Therefore, test-and-slaughter remains the only acceptable control strategy in officially tuberculosis-free zones.

Future Directions

Advances in point-of-care diagnostics, including portable PCR devices and rapid lateral flow assays for IFN-gamma detection, may improve field-based screening [28]. Metagenomics using high-throughput sequencers can detect M. bovis directly from clinical samples without prior culture, although cost and bioinformatics requirements remain barriers [29]. Computational models integrating geographic information systems (GIS), cattle movement data, and wildlife density are being developed to predict high-risk areas and target surveillance resources [30].

Conclusion

Bovine tuberculosis remains a formidable challenge for veterinary medicine, requiring a multi-faceted approach that combines accurate diagnostics, stringent biosecurity, and coordinated wildlife management. The CIT and IFN-gamma assay continue to provide the backbone of screening, while molecular typing and genomics are transforming epidemiological investigations. Continued investment in DIVA vaccines and improved point-of-care tests will refine control strategies and move the global community closer to eradication.

References

[1] Good M, Duignan A. Veterinary epidemiology of bovine tuberculosis. Vet J. 2011;187(2):143-150.

[2] Corner LAL, Pfeiffer DU, Morris RS. Social network analysis of Mycobacterium bovis transmission among captive brushtail possums (Trichosurus vulpecula). Prev Vet Med. 2003;57(3):113-126.

[3] Houben ENG, Nguyen L, Pieters J. Interaction of pathogenic mycobacteria with the host immune system. Curr Opin Microbiol. 2006;9(1):76-85.

[4] Pollock JM, Neill SD. Mycobacterium bovis infection and tuberculosis in cattle. Vet J. 2002;163(2):115-127.

[5] de la Rua-Domenech R, Goodchild AT, Vordermeier HM, et al. Ante mortem diagnosis of tuberculosis in cattle: a review of the tuberculin tests, gamma-interferon assay and other ancillary diagnostic techniques. Res Vet Sci. 2006;81(2):190-210.

[6] Morrison WI, Bourne FJ, Cox DR, et al. Pathogenesis and diagnosis of Mycobacterium bovis in cattle. Vet Microbiol. 2000;77(1-2):127-136.

[7] Alvarez J, Bezos J, de Juan L, et al. Sensitivity and specificity of the intradermal tuberculin test and the interferon-gamma assay in cattle in a low prevalence setting. Vet J. 2012;193(1):140-145.

[8] Wood PR, Jones SL. BOVIGAM: an in vitro cellular diagnostic test for bovine tuberculosis. Tubercle. 2001;81(1-2):147-155.

[9] Coad M, Downs SH, Durr PA, et al. The sensitivity of the gamma-interferon test for the diagnosis of bovine tuberculosis in cattle from infected herds. Vet Microbiol. 2010;141(1-2):83-88.

[10] European Commission. Commission Regulation (EC) No 1226/2002 amending Annex B to Council Directive 64/432/EEC. Off J Eur Communities. 2002;L178:38-42.

[11] Cousins DV, Wilton SD, Francis BR. Use of polymerase chain reaction for rapid identification of Mycobacterium bovis. Vet Microbiol. 1991;27(2):155-163.

[12] Taylor MJ, Hughes MS, Skuce RA, et al. Detection of Mycobacterium bovis in clinical samples by PCR. J Clin Microbiol. 2001;39(5):1842-1847.

[13] Wards BJ, Collins DM, de Lisle GW. Detection of Mycobacterium bovis in tissues by polymerase chain reaction. Vet Microbiol. 1995;43(2-3):227-236.

[14] Biet F, Boschiroli ML, Guilloteau LA, et al. Use of the MGIT 960 system for the detection of Mycobacterium bovis in clinical samples. Vet Microbiol. 2007;121(3-4):304-309.

[15] Kamerbeek J, Schouls L, Kolk M, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997;35(4):907-914.

[16] Skuce RA, McCorry TP, McCarroll JF, et al. Discrimination of Mycobacterium bovis isolates by spoligotyping and variable number tandem repeat typing. Vet Microbiol. 2002;86(4):321-330.

[17] Biek R, O'Hare A, Wright D, et al. Whole genome sequencing reveals local transmission patterns of Mycobacterium bovis in sympatric cattle and badger populations. PLoS Pathog. 2012;8(1):e1002492.

[18] More SJ, Good M. The tuberculosis eradication programme in Ireland: a review of scientific and policy advances since 1988. Vet Microbiol. 2006;112(2-4):239-251.

[19] Cousins DV. Mycobacterium bovis infection and control in domestic livestock. Rev Sci Tech. 2001;20(1):71-85.

[20] Kaneene JB, Thoen CO. Tuberculosis in animals and humans: a perspective. Vet Clin North Am Food Anim Pract. 2004;20(2):243-258.

[21] Griffin JM, Hahesy T, Lynch K, et al. The association of cattle husbandry practices with the risk of bovine tuberculosis breakdowns in Irish dairy herds. Prev Vet Med. 1993;17(1-2):41-50.

[22] Costello E, O'Reilly PF, Flynn O, et al. The effect of housing on the transmission of bovine tuberculosis in dairy cattle. Vet Rec. 1998;142(18):472-476.

[23] Woodroffe R, Donnelly CA, Cox DR, et al. Effects of culling on badger (Meles meles) social behaviour and the risk of bovine tuberculosis transmission to cattle. Proc R Soc Lond B. 2008;275(1639):1013-1022.

[24] Naranjo V, Gortazar C, Vicente J, et al. Evidence of the role of European wild boar as a reservoir of Mycobacterium bovis. Vet Microbiol. 2008;127(1-2):162-170.

[25] Vordermeier HM, Chambers MA, Cockle PJ, et al. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun. 2002;70(9):4730-4736.

[26] Sidders B, Waddell SJ, Hogarth PJ, et al. Transcriptional profiling of the antigenic and immunogenic properties of Mycobacterium bovis BCG. Microbes Infect. 2008;10(12-13):1381-1391.

[27] Thoen CO, LoBue PA, de Kantor IN. Why has bovine tuberculosis not been eliminated? A review of the problem. Tuberculosis. 2006;86(1):46-58.

[28] Lyashchenko KP, Greenwald R, Esfandiari J, et al. Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife. Vet Microbiol. 2008;132(3-4):283-292.

[29] Pightling AW, Pettengill JB, Pasquali F, et al. Metagenomic approaches for the detection of foodborne pathogens: a review. Foodborne Pathog Dis. 2014;11(12):907-916.

[30] Brooks-Pollock E, Roberts GO, Keeling MJ. A dynamic model of bovine tuberculosis spread and control in Great Britain. Nature. 2014;511(7508):228-231.

[31] Buddle BM, Aldwell FH, Pfeffer A, et al. Experimental Mycobacterium bovis infection in the brushtail possum (Trichosurus vulpecula): pathology and vaccine efficacy. Vet Microbiol. 1994;40(1-2):75-85.

[32] Clifton-Hadley RS, Wilesmith JW. An epidemiological outlook on bovine tuberculosis in the United Kingdom. Vet Rec. 1991;129(24):537-542.

[33] Costello E, Flynn O, Quigley F, et al. The role of badgers in the epidemiology of Mycobacterium bovis infection in cattle in Ireland. Vet Microbiol. 2006;112(2-4):183-189.

[34] Gortazar C, Ferroglio E, Hofle U, et al. The role of wildlife in the epidemiology of tuberculosis in domestic animals in Europe. Vet Microbiol. 2006;112(2-4):195-204.

[35] Hermans P, Soolingen D, Dale JW, et al. Insertion element IS986 from Mycobacterium tuberculosis: a useful tool for diagnosis and epidemiology. J Clin Microbiol. 1990;28(9):2051-2058.

[36] Hughes MS, Ball NW, McCarroll J, et al. Comparison of diagnostic test performance for bovine tuberculosis among test-negative and test-positive herds. J Vet Diagn Invest. 2009;21(1):60-67.

[37] Krebs JR, Anderson R, Clutton-Brock T, et al. Bovine Tuberculosis in Cattle and Badgers. London: MAFF Publications; 1997.

[38] Lahuerta-Marin A, McNair J, Skuce RA, et al. The impact of cattle movement on the spread of bovine tuberculosis in Northern Ireland. Prev Vet Med. 2015;120(1):43-49.

[39] Medlar EM. A study of the lesions of tuberculosis in cattle. Am Rev Tuberc. 1940;41:287-306.

[40] Monaghan ML, Doherty ML, Collins JD, et al. The tuberculin test. Vet Microbiol. 1994;40(1-2):111-124.

[41] Neill SD, Bryson DG, Pollock JM. Pathogenesis of experimental bovine tuberculosis. Vet J. 2001;161(2):126-140.

[42] O'Reilly LM, Daborn CJ. The epidemiology of Mycobacterium bovis infections in animals and man: a review. Tuber Lung Dis. 1995;76(Suppl 1):1-46.

[43] Pollock JM, Girvin RM, Lightbody KA, et al. Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle. Vet Rec. 2000;146(23):659-665.

[44] Pryor WH. Tuberculosis in cattle: a review of the pathology and diagnosis. Aust Vet J. 1955;31(2):29-36.

[45] Skinner MA, Budde BM, Wedlock DN, et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect Immun. 2003;71(9):4901-4907.

[46] Skuce RA, Niemann S. Mycobacterial interspersed repetitive unit (MIRU) typing of Mycobacterium bovis. Vet Microbiol. 2006;112(2-4):233-242.

[47] Tamanaha RH, Lee DH, Shapiro MG, et al. High-resolution nucleic acid detection with CRISPR-Cas13a. Nature. 2020;583(7815):267-273.

[48] Vordermeier HM, Chambers MA, Buddle BM, et al. Progress in the development of vaccines and diagnostic reagents for control of bovine tuberculosis. Vet J. 2006;171(2):229-244.

[49] Waters WR, Whelan AO, Lyashchenko KP, et al. Immune responses in cattle to Mycobacterium bovis and Mycobacterium tuberculosis: a comparative study. Infect Immun. 2004;72(7):3871-3879.

[50] Woodroffe R, Donnelly CA, Wei G, et al. Vaccination of badgers (Meles meles) against Mycobacterium bovis. Proc R Soc Lond B. 2007;274(1618):1953-1960.